CBD and sleep are marketed together constantly, but the direct clinical research specifically on CBD and insomnia is thinner and more mixed than the marketing suggests. The most rigorous independent trial of pure CBD, 150 mg nightly for two weeks in adults with moderate-to-severe insomnia, found no significant difference from placebo on insomnia severity, sleep onset latency, sleep efficiency, or time spent awake after falling asleep. The only significant differences were in subjective well-being scores, not the core sleep measures. A 2022 systematic review found that of 34 relevant studies, only 2 actually focused specifically on patients with insomnia, meaning most of the evidence people cite for “CBD helps sleep” is extrapolated from research on anxiety, pain, or general wellness, not direct insomnia trials. This is educational information, not medical advice.
From the Practice
[RILEY: add a real observation here, for example how often clients ask about CBD for sleep, or what you tell them about managing expectations based on the actual research.]
What Does the Direct Research on CBD and Insomnia Actually Show?
The most relevant, rigorously designed study here is a 2024 randomized controlled pilot trial published in the Journal of Clinical Sleep Medicine, testing 150 mg of CBD nightly for two weeks in adults with moderate-to-severe insomnia, using both subjective reports and objective sleep tracking. The result was largely a null finding for sleep itself: insomnia severity, self-reported sleep onset latency, sleep efficiency, and wake after sleep onset did not significantly differ between the CBD group and placebo.
What did differ: the CBD group reported greater well-being scores throughout the trial, and showed one measure of improved objective sleep efficiency after two weeks specifically. The study’s own authors concluded that nightly CBD supplementation “was similar to placebo regarding most sleep outcomes while sustaining greater well-being, suggesting more prominent psychological effects” than direct sleep effects. That’s a meaningfully different, more modest claim than “CBD helps you sleep.”
What About the More Positive Studies?
There are more positive-sounding trials in circulation, and it’s worth understanding an important detail about them. A 2025 randomized crossover trial of 125 participants found a CBD-terpene formulation, not CBD alone, increased time spent in slow-wave and REM sleep over four weeks. This is a genuinely different product than pure CBD: it combined 300 mg of CBD with a specific blend of eight terpenes (aromatic plant compounds), making it harder to isolate whether any benefit came from the CBD itself, the terpenes, or their combination.
It’s also worth being transparent about funding: this specific trial was conducted in connection with Defined Research, the company that developed and sells the CBD-terpene product being tested, a detail that doesn’t necessarily invalidate the findings, but is relevant context when weighing how much confidence to place in the results compared to independently funded research.
At a Glance: CBD and Sleep Research
| Study | Design | Key Finding |
|---|---|---|
| Narayan et al., 2024, JCSM | 150 mg pure CBD, 2 weeks, RCT | No significant difference from placebo on insomnia severity, sleep onset, efficiency, or WASO; improved subjective well-being only |
| Wang et al., 2025, JCSM | 300 mg CBD + terpene blend, 4 weeks, crossover RCT (industry-affiliated) | Increased slow-wave and REM sleep time; different formulation than pure CBD |
| Systematic review, 2022 (PubMed) | 34 studies reviewed | Only 2 of 34 studies focused specifically on insomnia patients; most evidence drawn from anxiety, pain, or general wellness research |
How Much of the “CBD Helps Sleep” Evidence Is Actually About Sleep?
Less than the marketing implies. A 2022 systematic review searching for research on CBD and insomnia management found 34 eligible studies, but on closer inspection, only 2 of those 34 studies actually focused specifically on patients with diagnosed insomnia, and one of those two was a single case report, not a controlled trial. The rest of the evidence base was drawn from studies on anxiety, chronic pain, PTSD, and other conditions where sleep was a secondary or incidental measure, not the primary focus.
This matters because secondary sleep improvements in an anxiety or pain trial don’t necessarily generalize to someone whose main issue is insomnia itself. Much of what gets cited as “CBD sleep research” is really “CBD research where sleep was one of several things measured,” a meaningfully weaker evidence base than direct insomnia trials would provide.
Is CBD Regulated as a Sleep Treatment?
No. The FDA has approved a CBD-based medication (Epidiolex) for only two rare, severe forms of childhood epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. CBD has no FDA approval for sleep or insomnia, and CBD products sold for sleep are marketed as unregulated supplements, meaning the same product-quality concerns that affect the melatonin market, inconsistent labeling and variable actual content, apply here as well. CBD can also interact with a range of medications by affecting liver enzymes involved in drug metabolism, so it’s worth checking with a doctor or pharmacist before combining it with prescription medications.
If you’ve tried CBD for sleep without the results you expected, book a consultation with The Sleep Consultant so we can help you find what will actually address the underlying issue.
What the Research Shows
The most rigorous trial of pure CBD for insomnia found no significant benefit on core sleep measures. A 2024 randomized controlled pilot trial found 150 mg of nightly CBD performed similarly to placebo on insomnia severity, sleep onset latency, sleep efficiency, and wake after sleep onset, with the main significant difference being improved subjective well-being.
More positive trials tend to test different formulations, not pure CBD. A 2025 crossover trial found a CBD-terpene combination increased slow-wave and REM sleep, but this product differs meaningfully from standalone CBD, and the trial was conducted in connection with the company selling the tested product.
Most of the broader “CBD and sleep” evidence base isn’t actually insomnia-specific research. A 2022 systematic review found only 2 of 34 relevant studies focused specifically on insomnia patients, with the majority of evidence drawn from research on anxiety, pain, and other conditions where sleep was a secondary outcome.
CBD has no FDA approval for sleep and carries real interaction risks. Its only FDA-approved use is for two rare epilepsy syndromes, and because it affects liver enzymes involved in metabolizing many medications, checking for interactions before use is a reasonable precaution.
This article is for educational purposes only and is not a substitute for personalized medical advice, diagnosis, or treatment.
Want a Sleep Strategy Grounded in What Actually Works?
Join the free Sleep Nirvana Club course and community for practical, root-cause-first guidance: Join here
When to Seek Professional Help
- You’ve tried CBD for sleep without meaningful improvement in your actual sleep quality
- You’re taking prescription medications and want to check for potential interactions with CBD
- You’re using CBD to manage anxiety or pain that’s secondarily affecting your sleep, and want to address the primary issue directly
- You’re relying on CBD instead of investigating an underlying cause of chronic insomnia
- You want guidance on product quality, since CBD sleep products face similar labeling inconsistency issues as other unregulated supplements
Frequently Asked Questions
Does CBD actually help you sleep?
The most rigorous direct trial of pure CBD found no significant improvement in insomnia severity, sleep onset latency, sleep efficiency, or nighttime wakefulness compared to placebo, only a difference in subjective well-being. More positive results have come from different formulations combining CBD with terpenes, not standalone CBD.
Why do some CBD sleep studies show better results than others?
A lot depends on the exact product tested. Pure CBD trials have shown limited direct sleep benefit, while trials of CBD-terpene combination products have shown more promising results on objective sleep measures, though these are different products, and one such trial was conducted in connection with the company selling that specific formulation.
Is most of the research on CBD actually about sleep specifically?
No, and this is an important distinction. A systematic review found that of 34 studies related to CBD and insomnia management, only 2 focused specifically on diagnosed insomnia patients. Most of the broader evidence base comes from research on anxiety, pain, and other conditions where sleep was a secondary measure, not the primary focus.
Is CBD FDA-approved for sleep or insomnia?
No. The FDA has only approved a CBD medication (Epidiolex) for two rare, severe childhood epilepsy syndromes. CBD sold for sleep is marketed as an unregulated supplement, with no FDA approval or oversight specific to sleep or insomnia use.
Are there risks to taking CBD for sleep?
CBD can interact with a range of medications by affecting liver enzymes involved in drug metabolism, so checking with a doctor or pharmacist is a reasonable precaution if you take other medications. Product quality and label accuracy can also vary, since CBD sleep products are sold as unregulated supplements.
When to Work With a Sleep Consultant
CBD is heavily marketed as a sleep solution, but the direct, rigorous research doesn’t yet support it as a reliable fix for insomnia itself. If you’ve tried it without the results you hoped for, that’s consistent with what the evidence actually shows, not a sign you’re doing something wrong.
